Cambridge Investment Research Advisors »

G1 Therapeutics shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of G1 Therapeutics (GTHX) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in G1 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including G1 Therapeutics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in G1 Therapeutics by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $73k 17k 4.34
2023-12-31 $36k 12k 3.05
2021-12-31 $129k 13k 10.18
2021-09-30 $227k 17k 13.42
2021-06-30 $288k 13k 21.98
2021-03-31 $201k 8.4k 24.07

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corp Com (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Value Etf (VTV)

View all positions for Cambridge Investment Research Advisors

Top funds holding G1 Therapeutics

Vanguard Group
Raymond James & Associates
D. E. Shaw & Co
Standard Life Aberdeen
Marshall Wace
Schonfeld Strategic Advisors
Jacobs Levy Equity Management
Bank of America Corporation
Jane Street
Connor, Clark & Lunn Investment Management
Level Four Advisory Services
Two Sigma Investments
Man Group
Citadel Advisors
Two Sigma Advisers

View all funds holding G1 Therapeutics